CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-05 | Chandrasekhar Satishchandran Director | Grant or award · Option (Right to Buy) | +151,316 | 151,316 | ||
| 2025-06-05 | Coleman Blaise Director | Grant or award · Option (Right to Buy) | +151,316 | 151,316 | ||
| 2025-06-05 | Castillo Kirsten Director | Grant or award · Option (Right to Buy) | +151,316 | 151,316 | ||
| 2025-06-05 | Kompella Uday Director | Grant or award · Option (Right to Buy) | +151,316 | 151,316 | ||
| 2025-06-05 | Zhang Junge Director | Grant or award · Option (Right to Buy) | +151,316 | 151,316 | ||
| 2025-01-03 | Upadhyay Arun See Remarks | Shares withheld for taxes | −41,633 | $0.89 | $37K | 306,197 |
| 2025-01-03 | Musunuri Shankar Chief Executive Officer | Shares withheld for taxes | −177,146 | $0.89 | $158K | 1,832,723 |
| 2025-01-02 | Ramachandran Ramesh Chief Accounting Officer | Grant or award · Option (Right to Buy) | +350,146 | 350,146 | ||
| 2025-01-02 | Upadhyay Arun See Remarks | Grant or award · Option (Right to Buy) | +730,994 | 730,994 | ||
| 2025-01-02 | Musunuri Shankar Chief Executive Officer | Grant or award · Option (Right to Buy) | +1,827,485 | 1,827,485 | ||
| 2025-01-02 | Qamar Huma Chief Medical Officer | Grant or award · Option (Right to Buy) | +1,145,468 | 1,145,468 | ||
| 2024-11-26 | Fernandes Prabhavathi Director | Purchase | +10,000 | $0.91 | $9K | 10,000 |
| 2024-11-22 | Castillo Kirsten Director | Purchase | +25,000 | $0.91 | $23K | 75,000 |
| 2024-09-16 | Upadhyay Arun See Remarks | Shares withheld for taxes | −842 | $1.17 | $985 | 347,830 |
| 2024-06-28 | WHITTINGTON MARNA C Director | Grant or award · Option (Right to Buy) | +66,929 | 66,929 | ||
| 2024-06-28 | Kompella Uday Director | Grant or award · Option (Right to Buy) | +66,929 | 66,929 | ||
| 2024-06-28 | Castillo Kirsten Director | Grant or award · Option (Right to Buy) | +66,929 | 66,929 | ||
| 2024-06-28 | Zhang Junge Director | Grant or award · Option (Right to Buy) | +66,929 | 66,929 | ||
| 2024-06-28 | Fernandes Prabhavathi Director | Grant or award · Option (Right to Buy) | +66,929 | 66,929 | ||
| 2024-06-17 | Upadhyay Arun See Remarks | Shares withheld for taxes | −917 | $1.42 | $1K | 348,672 |
Page 2 of 27 · 525 trades